# Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes

> **NCT03975855** · — · COMPLETED · sponsor: **NeoDynamics AB** · enrollment: 140 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** NeoNavia® Biopsy System

## Key facts

- **NCT ID:** NCT03975855
- **Lead sponsor:** NeoDynamics AB
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-14
- **Primary completion:** 2021-06-30
- **Final completion:** 2023-04-11
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975855, "Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03975855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*